Novel antibiotics for the treatment of Gram-positive bacterial infections

Journal of Medicinal Chemistry

Volumn 45, Issue 19, 2002, Pages 4246-4253

  Brands, Michael ^a   Endermann, Rainer ^a   Gahlmann, Reinhold ^a   Krüger, Jochen ^a   Raddatz, Siegfried ^a   Stoltefuß, Jürgen ^a   Belov, Vladimir N ^b   Nizamov, Shamil ^b   Sokolov, Viktor V ^b   De Meijere, Armin ^b  

^a BAYER AG   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 [N [3 AMINO 6 (1 METHYLGUANIDIN 1 YL)HEXANOYL] N METHYLAMINO] 5,6 DIHYDRO 2 UREIDOPYRIMID 4(1H) ONE; ANTIBIOTIC AGENT; NATURAL PRODUCT; TAN 1057 A B; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; IC 50; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHYLATION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ARGININE; DIPEPTIDES; FEMALE; GRAM-POSITIVE BACTERIA; GUANIDINES; MICE; MICROBIAL SENSITIVITY TESTS; PYRIMIDINONES; SEPSIS; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037068442     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0111191     Document Type: Article

References (31)

1. Methicillin-resistance in Staphylococcus aureus - Molecular basis, novel targets and antibiotic therapy
2. Bacteria fight back
3. Evolution of antibiotic resistance in gram-positive pathogens
4. The future of antibiotics: Facing antibiotic resistance
5. Antibacterial leads from microbial natural products discovery
6. TAN-1057 A-D. New antibiotics with potent antibacterial activity against methicillin-resistant staphylococcus aureus
7. A new anti-MRSA dipeptide, tan-1057 A
8. Synthesis and antimicrobial evaluation of TAN-1057 A/B analogues
9. Total synthesis of the anti-MRSA peptide antibiotics TAN-1057 A-D
10. Total synthesis of TAN-1057 A/B, a new dipeptide antibiotic from Flexibacter sp. PK-74
11. Guanidine aus S-alkylisothioharnstoffen mit aminen
12. A convenient and versatile method for the synthesis of protected guanidines
13. Improved method for the preparation of guanidines
14. 2-promoted guanylation reaction: The scope and limitations
15. Inhibition of protein synthesis by Blasticidin S
16. First synthesis of blasticidic acid, a component amino acid in an antibiotic Blasticidin S
17. Trifluoroacetylation of amino acids and peptides by ethyl trifluoroacetate
18. Synthesis of monoamides of methotrexate from L-glutamic acid monoamide tert-butyl esters
19. Sialidase inhibitors related to zanamivir. Further SAR studies of 4-amino-4H-pyran-2-carboxylic acid 6-propylamides
20. Synthesis of phenoxyacetic acid derivatives as highly potent antagonists of gastrin/cholecystokinin-B receptors. II
21. Urethane protection derivatives of 1-guanylpyrazoles for the mild and efficient preparation of guanidines
22. Improved efficiency and selectivity in peptide synthesis: Use of triethylsilane as a carbocationic scavenger in deprotection of t-butyl esters and t-butoxycarbonyl-protected sites
23. Conversion of alcohols to protected guanidines using the mitsunobu protocol
24. Triurethane-protected guanidines and triflyldiurethane-protected guanidines: New reagents for guanidinylation reaction
25. Protein export in escherichia coli requires a soluble activity
26. E. coli S30 extract system for circular DNA